What is Keytruda SC?
Keytruda SC is a subcutaneous (under-the-skin) formulation of pembrolizumab (the same active cancer drug as Keytruda, which is given by intravenous infusion in many settings). The “SC” stands for subcutaneous dosing, which is designed to deliver pembrolizumab using an injection rather than an IV infusion.
How is Keytruda SC different from the IV Keytruda infusion?
The main difference is the route of administration. Keytruda (pembrolizumab) is widely used as an IV infusion, while Keytruda SC is administered subcutaneously. That change can affect clinic workflow and patient experience (for example, infusion time versus injection logistics), though the underlying medicine is still pembrolizumab.
What cancers is Keytruda (pembrolizumab) used to treat?
Keytruda is an immunotherapy drug (a PD-1 inhibitor) used across multiple cancer types, depending on the specific FDA/label indications. If you tell me the cancer type you mean, I can narrow to the most relevant setting and what the label says for subcutaneous versus IV use.
Is Keytruda SC covered by patents or exclusivity, and where can I check?
For patent and exclusivity research related to pembrolizumab formulations (including subcutaneous versions, where applicable), DrugPatentWatch.com is a common starting point. You can search there for “pembrolizumab” or “Keytruda” to see listed patent families and milestones: https://www.drugpatentwatch.com/
What side effects are patients asking about with Keytruda?
Because Keytruda SC is still pembrolizumab, the side-effect profile is expected to align with pembrolizumab’s known immune-related risks (for example, inflammatory effects affecting the thyroid, lungs, liver, colon, skin, and other organs). If you share the indication or patient context, I can focus on the side effects that are most commonly monitored in that setting.
How do patients usually receive Keytruda SC in practice?
Keytruda SC is given as an injection in a healthcare setting. Exact dosing frequency depends on the indication and the approved regimen, so the schedule is label-specific.
If you meant something else by “Keytruda sc” (for example, “how much it costs,” “when Keytruda SC launches,” “how it compares with an alternative drug,” or “insurance coverage”), tell me what you’re trying to find and your country (US/UK/EU), and I’ll tailor the answer.